ClinVar Miner

Submissions for variant NM_001330311.2(DVL1):c.1594del (p.Trp532fs)

dbSNP: rs797044835
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
3billion RCV000195250 SCV002012136 pathogenic Autosomal dominant Robinow syndrome 2 2021-10-02 criteria provided, single submitter clinical testing Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). It is not observed in the gnomAD v2.1.1 dataset (PM2). The variant was observed as assumed (i.e. paternity and maternity not confirmed) de novoo (3billion dataset, PM6). The variant has been reported as pathogenic/likely pathogenic without evidence for the classification (ClinVar ID: VCV000504195.6). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline.
GeneDx RCV003223617 SCV003919668 pathogenic not provided 2023-04-20 criteria provided, single submitter clinical testing Frameshift variant predicted to result in protein truncation, as the last 164 amino acids are replaced with 141 different amino acids, and other loss-of-function variants have been reported downstream in HGMD; Not observed at significant frequency in large population cohorts (gnomAD); Published functional studies suggest a damaging gain of function effect (Bunn et al., 2015); This variant is associated with the following publications: (PMID: 30266093, 25817016, 25817014, 32888393, 33237614, 35047859)
Labcorp Genetics (formerly Invitae), Labcorp RCV003223617 SCV005833820 pathogenic not provided 2025-01-08 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Trp507Glyfs*142) in the DVL1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 164 amino acid(s) of the DVL1 protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Robinow syndrome (PMID: 25817014, 25817016, 35047859). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 208045). For these reasons, this variant has been classified as Pathogenic.
OMIM RCV000195250 SCV000222663 pathogenic Autosomal dominant Robinow syndrome 2 2015-04-02 no assertion criteria provided literature only
GeneReviews RCV000195250 SCV000243849 not provided Autosomal dominant Robinow syndrome 2 no assertion provided literature only
Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine RCV000195250 SCV000256688 pathogenic Autosomal dominant Robinow syndrome 2 2020-09-30 no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.